Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Pharmacogenomic Testing in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of Pharmacogenomic Testing in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03270891).
- Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01491113).
- Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01937130).
- Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral Cytidine Deaminase Inhibitor (CDAi) in Patients With Myelodysplastic Syndromes (MDS): primary endpoint results, effect estimate with…
- Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01533077).
- Pharmacokinetic Study of 4 mg Nicotine Lozenge.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of 4 mg Nicotine Lozenge.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669122).
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03943888).
- Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa: primary endpoint results, effect estimate with confidence interval,…
- Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function: primary endpoint results, effect…
- Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01468558).
- Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl’s Solution in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pharmacokinetics and Hepatic Safety of EGCG: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Hepatic Safety of EGCG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04177693).
- Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340586).
- Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00652028).
- Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pharmacokinetics of Advantage Anti-Caries Varnish: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Advantage Anti-Caries Varnish: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04183231).
- Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00877370).
- Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04079790).
- Pharmacokinetics of JULUCA in Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of JULUCA in Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04431518).
- Pharmacokinetics of Linezolid in Children With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Linezolid in Children With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00625703).
- Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese Subjects: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01179919).
- Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00555061).
- Pharmacokinetics of Ridaforolimus (MK-8669) in Chinese Participants (MK-8669-059): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Ridaforolimus (MK-8669) in Chinese Participants (MK-8669-059): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01380184).
- Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01667796).
- Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment: primary endpoint results, effect estimate…